Should you buy CHRN stock?
Last updated:
Based on market data through , StockInvest.us rates Ekso Bionics Holdings, Inc. Common Stock (CHRN) as a Sell Candidate with a technical score of -2.78 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Sell signal since
- Price since signal Down 4.25%
- 3-month trend forecast Up 31.23%
- Easy Tracking In The Watchlist
Is Ekso Bionics Holdings, Inc. Common Stock stock still a buy after falling -7.36% on Monday?
(Market data through Aug 10, 2026)
The Ekso Bionics Holdings, Inc. Common Stock stock price fell by -7.36% on the last day (Monday, 10th Aug 2026) from $20.93 to $19.39. During the last trading day the stock fluctuated 3.09% from a day low at $19.06 to a day high of $19.65. The price has been going up and down for this period, and there has been a -4.29% loss for the last 2 weeks. Volume has increased on the last day by 251 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 361 thousand shares were bought and sold for approximately $7.00 million.
Given the current short-term trend, the stock is expected to rise 31.23% during the next 3 months and, with a 90% probability hold a price between $25.45 and $41.77 at the end of this 3-month period.
CHRN Signals & Forecast
There are few to no technical positive signals at the moment. The Ekso Bionics Holdings, Inc. Common Stock stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $22.05 and $22.15. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 15, 2026, and so far it has fallen -34.56%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Ekso Bionics Holdings, Inc. Common Stock stock
On the downside, the stock finds support just below today's level from accumulated volume at $18.29 and $17.64. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Ekso Bionics Holdings, Inc. Common Stock finds support just below today's level at $18.29. If this is broken, then the next support from accumulated volume will be at $17.64 and $16.63.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.589 between high and low, or 3.09%. For the last week, the stock has had daily average volatility of 9.16%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CHRN) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Ekso Bionics Holdings, Inc. Common Stock to open at $19.37, and during the day (based on 14 day Average True Range), to move between $17.95 and $20.83, which gives a possible trading interval of +/-$2.88 (+/-16.04%) up or down from last closing price. If Ekso Bionics Holdings, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 16.04% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $18.29 (5.67%) than the resistance at $22.51 (16.09%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Ekso Bionics Holdings, Inc. Common Stock stock A Buy?
The Ekso Bionics Holdings, Inc. Common Stock stock holds several negative signals and despite the positive trend, we believe Ekso Bionics Holdings, Inc. Common Stock will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score:
-2.781
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $19.37 ( 0.119%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
CHRN Performance
Trading levels for CHRN
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 19.96 | 2.92% |
| R2 | 19.73 | 1.76% |
| R1 | 19.59 | 1.04% |
| Price | 19.39 | |
| S1 | 19.14 | -1.28% |
| S2 | 19.00 | -2.00% |
| S3 | 18.78 | -3.16% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 23.36 | 20.47% |
| R2 | 23.33 | 20.32% |
| R1 | 22.51 | 16.09% |
| Price | 19.39 | |
| S1 | 18.29 | -5.67% |
| S2 | 17.64 | -9.03% |
| S3 | 16.63 | -14.23% |
FAQ
Click here for our free guide on how to buy Ekso Bionics Holdings, Inc. Common Stock Stock.
Buy CHRN